Lesson plan

Tirap

TIRAP (TIR domain containing adaptor protein), also known as MAL (MyD88 adaptor-like protein) is an adapter protein associated with Toll-like receptors (TLRs), specifically TLR2 and TLR4. The innate immune system recognizes microbial pathogens through Toll-like receptors (TLRs), which identify pathogen-associated molecular patterns. Different TLRs recognize different pathogen-associated molecular patterns and all TLRs have a Toll-interleukin 1 receptor (TIR) domain, which is responsible for signal transduction. The protein encoded by this gene is a TIR adaptor protein involved in the TLR4 signaling pathway of the immune system. In TLR2 and TLR4, TIRAP is required for the MyD88-dependent pathway of immune signalling. In TLR2 and TLR4 signalling, TIRAP facilitates MyD88 recruitment which allows for downstream activation of NF-kappa-B, MAPK1, MAPK3 and JNK, which then results in cytokine secretion and the inflammatory response. Alternative splicing of this gene results in several transcript variants; however, not all variants have been fully described.

Back to article

Article summary

TIRAP (TIR domain containing adaptor protein), also known as MAL (MyD88 adaptor-like protein) is an adapter protein associated with Toll-like receptors (TLRs), specifically TLR2 and TLR4. The innate immune system recognizes microbial pathogens through Toll-like receptors (TLRs), which identify pathogen-associated molecular patterns. Different TLRs recognize different pathogen-associated molecular patterns and all TLRs have a Toll-interleukin 1 receptor (TIR) domain, which is responsible for signal transduction. The protein encoded by this gene is a TIR adaptor protein involved in the TLR4 signaling pathway of the immune system. In TLR2 and TLR4, TIRAP is required for the MyD88-dependent pathway of immune signalling. In TLR2 and TLR4 signalling, TIRAP facilitates MyD88 recruitment which allows for downstream activation of NF-kappa-B, MAPK1, MAPK3 and JNK, which then results in cytokine secretion and the inflammatory response. Alternative splicing of this gene results in several transcript variants; however, not all variants have been fully described.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.